PATENT CLAIM ANALYSIS

Application Number: 16069487
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2019-07
Patent Classification: ["424", "133100"]

Abstract:
The present disclosure provides antibodies that bind Lymphocyte Activation Gene-3 (LAG-3). Also provided are methods of stimulating an immune response, inhibiting growth of tumor cells, and treating an autoimmune, inflammatory, or viral disease.

Claim (Index 56):
The method of  claim 44 , wherein the amino acid substitution from SEQ ID NO:243 is at amino acid residue N28, according to Kabat numbering.

Metadata:
- Claim Count in Document: 59.0
- Percentile: 95.0
- Lexical Diversity: 1.17143
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15166305', '15254315', '15636610', '14472116', '15211504']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7012829574511146
- 35 USC 102 Novelty (BERT): 0.5446306508234189
- Combined Prediction Score: 0.685617726788345
- Mean Citation Score: 363.044838
- Max Citation Score: 381.17462
- Similarity Product: 243.4672748049664

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test